Harm/ risk (analysis)

Citations 1-7 of 7 total displayed.

Most recent content (29 Jul 2008):

ARTICLES
Quantitative risk-benefit analysis of natalizumab

J. P. Thompson, K. Noyes, E. R. Dorsey, S. R. Schwid, and R. G. Holloway
Neurology 2008; 71: 357-364. [Abstract] [Full text] [PDF]  

Past content (since Jul 2003):

EDITORIALS
Medical errors after stroke: Preventable or inevitable?

Matthew Rizzo and Thomas H. Glick
Neurology 2007; 68: 542-543. [Full text] [PDF]  

SPECIAL ARTICLES
Neurologists for patient safety: Where we stand, time to deliver

Thomas H. Glick, Matthew Rizzo, Barney J. Stern, and Daniel M. Feinberg
Neurology 2006; 67: 2119-2123. [Abstract] [Full text] [PDF]  

EDITORIALS
Improving patient safety: What can detailed case analysis tell us?

Lois Margaret Nora and Spencer L. Studwell
Neurology 2005; 65: 1154-1155. [Full text] [PDF]  

BRIEF COMMUNICATIONS
Neurologic patient safety: An in-depth study of malpractice claims

Thomas H. Glick, Lee D. Cranberg, Robert B. Hanscom, and Luke Sato
Neurology 2005; 65: 1284-1286. [Abstract] [Full text] [PDF]  

ARTICLES
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology

M.A. Pappolla, T.K. Bryant-Thomas, D. Herbert, J. Pacheco, M. Fabra Garcia, M. Manjon, X. Girones, T.L. Henry, E. Matsubara, D. Zambon, B. Wolozin, M. Sano, F.F. Cruz-Sanchez, L.J. Thal, S.S. Petanceska, and L.M. Refolo
Neurology 2003; 61: 199-205. [Abstract] [Full text] [PDF]  

BRIEF COMMUNICATIONS
Medical errors on an inpatient neurology service

Samuel Frank and Robert Holloway
Neurology 2003; 61: 254-257. [Abstract] [Full text] [PDF]